Cargando…
Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis—A Randomized Placebo Controlled Clinical Trial
In December 2019 the SARS-CoV-2 virus appeared in the world, mainly presenting as an acute infection of the lower respiratory tract, namely pneumonia. Nearly 10% of all patients show significant pulmonary fibrotic changes after the infection. The aim of this study was to evaluate the effectiveness a...
Autores principales: | Kotfis, Katarzyna, Karolak, Igor, Lechowicz, Kacper, Zegan-Barańska, Małgorzata, Pikulska, Agnieszka, Niedźwiedzka-Rystwej, Paulina, Kawa, Miłosz, Sieńko, Jerzy, Szylińska, Aleksandra, Wiśniewska, Magda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874492/ https://www.ncbi.nlm.nih.gov/pubmed/35215312 http://dx.doi.org/10.3390/ph15020200 |
Ejemplares similares
-
The Effect of Potassium Canrenoate (Mineralocorticoid Receptor Antagonist) on the Markers of Inflammation in the Treatment of COVID-19 Pneumonia and Fibrosis—A Secondary Analysis of Randomized Placebo-Controlled Clinical Trial
por: Karolak, Igor, et al.
Publicado: (2023) -
COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection
por: Kotfis, Katarzyna, et al.
Publicado: (2021) -
Acute and Chronic Pain Learning and Teaching in Medical School—An Observational Cross-Sectional Study Regarding Preparation and Self-Confidence of Clinical and Pre-Clinical Medical Students
por: Lechowicz, Kacper, et al.
Publicado: (2019) -
Current Evidence Regarding Biomarkers Used to Aid Postoperative Delirium Diagnosis in the Field of Cardiac Surgery—Review
por: Majewski, Paweł, et al.
Publicado: (2020) -
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
por: Lechowicz, Kacper, et al.
Publicado: (2020)